Allakos Inc. (ALLK) Financial Statements (2026 and earlier)

Company Profile

Business Address 825 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:80,800,000170,800,000279,800,000424,200,000659,000,000495,900,000
Cash and cash equivalent17,753,00066,440,00087,217,000152,822,000207,177,00038,367,000
Short-term investments63,067,000104,354,000192,569,000271,416,000451,820,000457,534,000
Other undisclosed cash, cash equivalents, and short-term investments(20,000)6,00014,000(38,000)3,000(1,000)
Restricted cash and investments 1,472,000     
Prepaid expense1,449,0001,092,0001,741,000   
Other undisclosed current assets1,865,0007,997,00027,302,00027,381,00010,267,0003,970,000
Total current assets:85,586,000179,889,000308,843,000451,581,000669,267,000499,870,000
Noncurrent Assets
Operating lease, right-of-use asset  24,136,00030,225,00031,707,00039,731,0005,775,000
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization10,827,00033,369,00039,144,00043,100,0008,345,0008,410,000
Other noncurrent assets 188,0006,216,0008,208,0008,436,0002,275,0002,839,000
Total noncurrent assets:11,015,00063,721,00077,577,00083,243,00050,351,00017,024,000
TOTAL ASSETS:96,601,000243,610,000386,420,000534,824,000719,618,000516,894,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,784,00036,578,00030,038,00040,249,00022,450,00013,061,000
Accounts payable5,490,0001,764,0004,832,00013,692,00013,960,0005,963,000
Accrued liabilities12,294,00034,814,00025,206,00026,557,0008,490,0007,098,000
Total current liabilities:17,784,00036,578,00030,038,00040,249,00022,450,00013,061,000
Noncurrent Liabilities
Long-term debt and lease obligation:    49,099,00042,773,000 
Liabilities, other than long-term debt  38,215,00045,949,000  8,112,000
Other liabilities      8,112,000
Operating lease, liability  38,215,00045,949,00049,099,00042,773,000 
Other undisclosed noncurrent liabilities    (49,099,000)(42,773,000) 
Total noncurrent liabilities:  38,215,00045,949,00049,099,00042,773,0008,112,000
Total liabilities:17,784,00074,793,00075,987,00089,348,00065,223,00021,173,000
Equity
Equity, attributable to parent78,817,000168,817,000310,433,000445,476,000654,395,000495,721,000
Common stock90,00088,00085,00054,00053,00048,000
Additional paid in capital1,312,886,0001,287,156,0001,243,408,0001,058,399,000997,298,000685,020,000
Accumulated other comprehensive income (loss)136,00050,000(284,000)(153,000)8,000137,000
Accumulated deficit(1,234,295,000)(1,118,477,000)(932,776,000)(612,824,000)(342,964,000)(189,484,000)
Total equity:78,817,000168,817,000310,433,000445,476,000654,395,000495,721,000
TOTAL LIABILITIES AND EQUITY:96,601,000243,610,000386,420,000534,824,000719,618,000516,894,000

Income Statement (P&L) (USD)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating expenses(122,225,000)(196,056,000)(322,429,000)(271,475,000)(157,057,000)(91,418,000)
Operating loss:(122,225,000)(196,056,000)(322,429,000)(271,475,000)(157,057,000)(91,418,000)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(43,000)8,000(1,196,000)1,238,000(736,000)(155,000)
Loss from continuing operations before equity method investments, income taxes:(122,268,000)(196,048,000)(323,625,000)(270,237,000)(157,793,000)(91,573,000)
Other undisclosed income from continuing operations before income taxes      6,201,000
Loss from continuing operations:(122,268,000)(196,048,000)(323,625,000)(270,237,000)(157,793,000)(85,372,000)
Loss before gain (loss) on sale of properties:(270,237,000)(157,793,000)(85,372,000)
Other undisclosed net income     4,313,000 
Net loss:(122,268,000)(196,048,000)(323,625,000)(270,237,000)(153,480,000)(85,372,000)
Other undisclosed net income attributable to parent6,450,00010,347,0003,673,000377,000  
Net loss available to common stockholders, diluted:(115,818,000)(185,701,000)(319,952,000)(269,860,000)(153,480,000)(85,372,000)

Comprehensive Income (USD)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(122,268,000)(196,048,000)(323,625,000)(270,237,000)(153,480,000)(85,372,000)
Comprehensive loss:(122,268,000)(196,048,000)(323,625,000)(270,237,000)(153,480,000)(85,372,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent6,536,00010,681,0003,542,000216,000(129,000)152,000
Comprehensive loss, net of tax, attributable to parent:(115,732,000)(185,367,000)(320,083,000)(270,021,000)(153,609,000)(85,220,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: